COVID-19: What type of cytokine storm are we dealing with?

Monneret, Guillaume; Benlyamani, Ihsane; Gossez, Morgane; Bermejo-Martin, Jesus F; Martín-Fernandez, Marta; Sesques, Pierre; Wallet, Florent; Venet, Fabienne

Monneret, Guillaume; Benlyamani, Ihsane; Gossez, Morgane; Bermejo-Martin, Jesus F; Martín-Fernandez, Marta; Sesques, Pierre; Wallet, Florent; Venet, Fabienne.

Monneret G; EA 7426 "Pathophysiology of Injury-Induced Immunosuppression (PI3)," Claude Bernard Lyon 1 University Hospices Civils de Lyon-bioMérieux, Lyon, France.
Benlyamani I; Immunology Department, Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
Gossez M; Immunology Department, Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
Bermejo-Martin JF; EA 7426 "Pathophysiology of Injury-Induced Immunosuppression (PI3)," Claude Bernard Lyon 1 University Hospices Civils de Lyon-bioMérieux, Lyon, France.
Martín-Fernandez M; Immunology Department, Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
Sesques P; Biomedical research Department, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Wallet F; Biomedical research Department, Hospital Universitario Río Hortega de Valladolid, Valladolid, Spain.
Venet F; Biomedical research Department, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.

J Med Virol ; 93(1): 197-198, 2021 01.

Article in English | MEDLINE | ID: covidwho-651592

Subject(s)

COVID-19 Drug Treatment; Cytokine Release Syndrome; Antibodies, Monoclonal, Humanized; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytokine Release Syndrome / COVID-19 Drug Treatment Limits: Humans Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26317

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google